Because U.S. human papillomavirus (HPV) vaccination rates remain low, we evaluated school nurses’ knowledge, attitudes, perceptions of their role as opinion leaders, self-efficacy, intention, and professional practice regarding the HPV vaccine and determined if these variables influenced their professional practice concerning the HPV vaccine. We utilized a cross-sectional design by recruiting Ohio Association of School Nurses (OASN) members. Participants (n = 145) completed a paper survey during the OASN annual conference. Structural equation modeling was used to examine the proposed model. Our model yielded a well-fitting solution, χ2 = 1.118 (degrees of freedom = 2, p = .57). Knowledge had positive effects on intention and self-efficacy. Attitude had a positive effect on perception of role as opinion leaders. Intention to provide HPV vaccine education had a positive effect on professional practice. To develop school nurses’ practice, interventions should center on increasing knowledge, attitudes, and intention toward providing HPV vaccine education.
American Academy of Pediatrics Council on School Health. (2008). Role of the school nurses in providing school health services. Journal of School Nursing, 24, 269–274.
2.
AskelsonN. M.CampoS.LoweJ. B.SmithS.DennisL. K.AndsagerJ. (2010). Using the theory of planned behavior to predict mothers’ intentions to vaccinate their daughters against HPV. Journal of School Nursing, 26, 194–202.
3.
BaischM. J.LundeenS. P.MurphyM. K. (2011). Evidence-based research on the value of school nurses in an urban school system. Journal of School Health, 81, 74–80.
4.
BartlettJ. A.PetersonJ. A. (2011). The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: A review of the literature. Journal of School Nursing, 27, 434–446.
5.
BartlettJ. A.PetersonJ. A. (2013). Psychometric evaluation of the shared decision-making instrument—revised. Western Journal of Nursing Research, 35, 193–213.
6.
Bellia-WeissT.ParsonsM.SebachA. M.RockelliL. A. (2013). Promoting HPV prevention in the school setting. NASN School Nurse, 28, 86–93.
7.
BennettM. P. (2008). Ethics and the HPV vaccine: Considerations for school nurses. The Journal of School Nursing, 24, 275–283.
BoehnerC. W.HoweS. R.BernsteinD. I.RosenthalS. L. (2003). Viral sexually transmitted disease vaccine acceptability among college students. Sexually Transmitted Diseases, 30, 774–778.
10.
BollenK. A. (1989). Structural equations with latent variables. New York, NY: John Wiley & Sons Inc.
11.
BrewerN. T.FazekasK. I. (2007). Predictors of HPV vaccine acceptability: A theory-informed, systematic review. Preventive Medicine, 45, 107–114.
12.
BrissP.RimerB.ReilleyB.CoatesR. C.LeeN. C.MullenP., … Task Force on Community Preventive Services. (2004). Promoting informed decisions about cancer screening in communities and healthcare systems. American Journal of Preventive Medicine, 26, 67–80.
13.
BrowneM. W.CudeckR. (1993). Alternative ways of assessing model fit. In BollenK. A.LongJ. S. (Eds.), Testing structural equation models (pp. 136–162). Newbury Park, CA: Sage.
14.
ByrneB. M. (2001). Structural equation modeling with AMOS: Basic concepts, applications, and programming. Mahwah, NJ: Lawrence Erlbaum Associates.
15.
Centers for Disease Control and Prevention. (1999). Ten great public health achievements—United States, 1900-1999. Morbidity and Mortality Weekly Report, 48, 241–243.
16.
Centers for Disease Control and Prevention. (2010). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report, 59, 630–632.
Centers for Disease Control and Prevention. (2013c). National and state vaccination coverage among adolescents aged 13 through 17 years-united states, 2012. Morbidity and Mortality Weekly Report, 62, 685–693.
21.
Committee on Infectious Diseases. (2007). Prevention of human papillomavirus infection: Provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccine. Pediatrics, 120, 666–668.
22.
Council on School Health. (2008). The American Academy of Pediatrics policy statement: The role of the school nurse in providing school health services. Journal of School Nursing, 24, 269–274.
23.
CowellJ. M. (2010). Reproductive and gender health. Journal of School Nursing, 26, 88–90.
24.
DavisK.DickmanE. D.FerrisD.DiasJ. K. (2004). Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. Journal of Lower Genital Tract Disease, 8, 188–194.
25.
DearingJ. W. (2009). Applying diffusion of innovation theory to intervention development. Research on Social Work Practice, 19, 503–518.
26.
DempseyA. F.ZimetG. D.DavisR. L.KoutskyL. (2006). Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics, 117, 1486–1493.
27.
DunneE. F.UngerE. R.SternbergM.McQuillanG.SwanD. C.PatelS. S.MarkowitzL. E. (2007). Prevalence of HPV infection among females in the United States. Journal of American Medical Association, 297, 813–819.
28.
EndersC. K. (2010). Applied missing data analysis. New York, NY: Guilford Press.
29.
FisherR.DarrowD. H.TranterM.WilliamsJ. V. (2008). Human papillomavirus vaccine: Recommendations, issues and controversies. Current Opinion in Pediatrics, 20, 441–445.
GambleH. L.KloskyJ. L.ParraG. R.RandolphM. E. (2010). Factors influencing familial decision-making regarding human papillomavirus vaccination. Journal of Pediatric Psychology, 35, 704–715.
32.
GarciniL. M.GalvanT.Barnack-TavlarisJ. L. (2012). The study of human papillomavirus (HPV) vaccine uptake from a parental perspective: A systematic review of observational studies in the United States. Vaccine, 30, 4588–4595.
33.
GerendM. A.LeeS. C.ShepherdJ. E. (2006). Predictors of human papillomavirus vaccination acceptability among underserved women. Sexually Transmitted Diseases, 33, 1–4.
34.
GreenL. W.OttosonJ. M.GarciaC.HiattR. A. (2009). Diffusion theory and knowledge dissemination utilization and integration in public health. Annual Review of Public Health, 30, 151–174.
35.
HuL.BentlerP. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1–55.
36.
JensonH. B. (2009). Human papillomavirus vaccine: A paradigm shift for pediatricians. Current Opinion in Pediatrics, 21, 112–121.
37.
KahnJ. A.RosenthalS. L.HamannT.BernsteinD. I. (2003). Attitudes about human papillomavirus vaccine in young women. International Journal of STD & AIDS, 14, 300–306.
38.
KennyD. A.KaniskanB.McCoachD. B. (2014). The performance of RMSEA in models with small degrees of freedom. Sociological Methods & Research. Advance online publication. doi: 10.1177/0049124114543236
39.
KesselsS. J. M.MarshallH. S.WatsonM.Braunack-MayerA. J.ReuzelR.TooherR. L. (2012). Factors associated with HPV vaccine uptake in teenage girls: A systematic review. Vaccine, 30, 3546–3556.
40.
KimmelS. R. (2006). Practical implementation of HPV vaccines in clinical practice. Journal of Family Practice, 55, 18–22.
41.
KirchoferG.TelljohannS. K.PriceJ. H.DakeJ. A.RitchieM. (2007). Elementary school parents’/guardians’ perceptions of school health service personnel and the services they provide. Journal of School Health, 77, 607–614.
42.
KlineR. B. (2010). Principles and practice of structural equation modeling (3rd ed.). New York, NY: The Guilford Press.
43.
LittleR.RubinD. (2002). Statistical analysis with missing data. New York, NY: John Wiley.
44.
LittleT. D.LindenbergerU.NesselroadeJ. R. (1999). On selecting indicators for multivariate measurement and modeling with latent variables: When “good” indicators are bad and “bad” indicators are good. Psychological Methods, 4, 192–211.
45.
Lockwood-RayermannS.McIntyreS. J. (2009). Understanding HPV disease and prevention: A guide for school nurses. Journal of School Nursing, 25, 261–269.
46.
MathurM. B.MathurV. S.ReichlingD. B. (2010). Participation in the decision to become vaccinated against human papillomavirus by California high school girls and the predictors of vaccine status. Journal of Pediatric Healthcare, 24, 14–24.
47.
MaughanE.AdamsR. (2011). Educators’ and parents’ perception of what school nurses do: The influence of school nurse/student ratios. The Journal of School Nursing, 27, 355–363.
48.
MuthénB. O.du ToitS. H. C.SpisicD. (1997). Robust inference using weighted least squares and quadratic estimating equations in latent variable modeling with categorical and continuous outcomes. Unpublished manuscript.
49.
NagarajA. (2006). Does qualitative synthesis of anecdotal evidence with that from scientific research help in understanding public health issues: A review of low MMR uptake. European Journal of Public Health, 16, 85–88.
National Cancer Institute. (2005). Theory at a glance: A guide for health promotion practice (2nd ed.). Bethesda, MD: US Department of Health and Human Services.
52.
National Cancer Institute. (2014). Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. A report to the President of the United States from the President’s Cancer Panel. Bethesda, MD: National Cancer Institute.
53.
OlshenE.WoodsE. R.AustinS. B.LuskinM.BauchnerH. (2005). Parental acceptance of the human papillomavirus vaccine. Journal of Adolescent Health, 37, 248–251.
54.
RobertoA. J.KriegerJ. L.KatzM. L.GoeiR.JainP. (2011). Predicting pediatricians’ communication with parents about the human papillomavirus (HPV) vaccine: An application of the Theory of Reasoned Action. Health Communication, 26, 303–312.
55.
RogersE. M. (2003). Diffusion of innovations (5th ed.). New York, NY: Free Press.
56.
RogersE. M. (2002). Diffusion of prevention innovations. Addictive Behaviors, 27, 989–993.
57.
RosenB.GoodsonP. (2013–2014). A recommendation to use the diffusion of innovations theory to understand school nurses’ role in HPV vaccine uptake. International Quarterly of Community Health Education, 34, 37–49.
58.
RosenB. L.GoodsonP.FosterM. (2013). Healthcare providers and the HPV vaccine: A systematic review. Unpublished manuscript.
59.
RosenB. L.GoodsonP.ThompsonB.WilsonK. L. (2015). School nurses’ knowledge, attitudes, perceptions, and professional practice regarding HPV vaccine for youth. Journal of School Health, 85, 73–81.
60.
SalantP.DillmanD. A. (1994). How to conduct your own survey. New York, NY: John Wiley.
61.
SerpellL.GreenJ. (2006). Parental decision-making in childhood vaccination. Vaccine, 24, 4041–4046.
62.
SheeranP. (2002). Intention-behavior relations: A conceptual and empirical review. In StroebeW.HewstoneM. (Eds.), European review of social psychology (12th ed., pp. 1–36). Chichester, England: John Wiley.
63.
ShengY.ShengZ. (2012). Is coefficient alpha robust to non-normal data?Frontiers in Psychology, 3, 34. doi:10.3389/fpsyg.2012.00034
64.
ValenteT. W.PumpuangP. (2007). Identifying opinion leaders to promote behavior change. Health Education Behavior, 34, 881–896.
65.
WeinstockH.BermanS.CatesW. J. (2004). Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspectives on Sexual and Reproductive Health, 36, 6–10.
66.
ZimetG. D. (2005). Improving adolescent health: Focus on HPV vaccine acceptance. Journal of Adolescent Health, 37, S17–S23.
67.
ZimetG. D. (2006). Understanding and overcoming barriers to human papillomavirus vaccine acceptance. Current Opinion in Obstetrics & Gynecology, 18, s23–s28.
